Evidence map›Paper›PMID 37368266›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Biofunctionalization of HMX with Peptides via Polydopamine Crosslinking for Assembling an HMX@Al@CuO Nanoenergetic Composite.

Miaomiao Jin, Zhanxin Song, Wei Liu, Guozhen Wang, Mo Xian

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Facile Fabrication of Energetic Nanocomposite Materials by Polydopamine.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miaomiao JinCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.
Zhanxin SongCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.
Wei LiuInstitute of Corrosion Science and Technology, Guangzhou 510530, China.
Guozhen WangCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.
Mo XianCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.

Funding

National Natural Science Foundation of China 22005326Taishan Scholars Project of Shandong ts201712076
6 · The paper itself

Abstract

Biological approaches for the synthesis of a hybrid explosive-nanothermite energetic composite have attracted greater scientific attention because of their advantages, including their moderate reactions and the absence of secondary pollution. In this study, a simple technique was developed to fabricate a hybrid explosive-nanothermite energetic composite based on a peptide and a mussel-inspired surface modification. Polydopamine (PDA) was easily imprinted onto the HMX, where it maintained its reactivity and was capable of reacting with a specific peptide used to introduce Al and CuO NPs to the surface of the HMX via specific recognition. The hybrid explosive-nanothermite energetic composites were characterized using differential scanning calorimetry (TG-DSC), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy(XPS), and a fluorescence microscope. A thermal analysis was utilized to investigate the energy-release properties of the materials. The HMX@Al@CuO, which benefitted from an enhanced interfacial contact in comparison with the physically mixed sample (HMX-Al-CuO), demonstrated a 41% lower HMX activation energy.

Indexed as

activation energybiological self-assemblygreen preparationpeptidepolydopamine

Identifiers

PMID37368266
PMCPMC10301552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.